Stay updated on ARGX-113 in Myasthenia Gravis: Safety Trial

Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-113 in Myasthenia Gravis: Safety Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Napoli, Italy (80131) site name changed to Naples, Italy (80131). Expanded Access note 'Available outside the clinical trial' added and page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-25T20:52:07.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Site revision information updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:12:01.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the older funding-status notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:20:00.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status and NIH Clinical Center operations has been added. The page revision version was updated from 3.4.0 to 3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T00:28:27.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page now shows a glossary and the field 'Last Update Submitted that Met QC Criteria.' A new revision label 'v3.4.0' was added, replacing 'v3.3.4,' and there are capitalization updates to 'No FEAR Act' data.
    Difference
    0.2%
    Check dated 2026-01-28T00:27:33.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The study locations are reorganized to show individual sites by region (e.g., California, Florida, Ontario, Tokyo), and the HHS Vulnerability Disclosure footer was removed.
    Difference
    1%
    Check dated 2025-12-23T08:13:53.000Z thumbnail image

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Safety Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.